ArticleCancer biology & therapy2016

Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme.

Filiz Senbabaoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.